Two important events happened in the ASPREE Healthy Ageing Biobank this week. Opening of a new storage facility for...
Clinicians
Aspirin, DNA and Cancer: ASPREE comment on JAMA paper
A recent report that an individual’s genetic make-up could determine whether aspirin had a positive or negative effect...
New record for ASPREE study update attendees in Melbourne
More than 700 ASPREE participants and guests attended ASPREE study updates at the Monash Biomedical Imaging (MBI)...
Adelaide and Melbourne hosts study updates
The second study update in Adelaide Adelaide Chief Investigator hosts study update in Salisbury Professor Nigel...
2014. What a Year!
A summary of highlights for the ASPREE trial as recruitment phase ends Thanks to the wonderful support from...
ASPREE Study Update in Hobart
Chief Investigator to ASPREE in Tasmania, Professor Mark Nelson, hosted the ASPREE Hobart study update at the Menzies...
ASPREE Study Update in Frankston
Frankston turned on the weather at the 19th update this year Participants and guests living in south-east...
ASPREE Study Updates in Gippsland
Presentations held in Traralgon and Bairnsdale Wonderful to meet so many ASPREE participants and guests in...
A letter from ASPREE PI, Professor John McNeil, to Australian participants and GPs
To our ASPREE participants and GP Associate Investigators, The ASPREE team sincerely thanks you for supporting...
ASPREE Investigator interview on Radio National Health Report
A recap on aspirin and primary prevention aspirin trials Professor Mark Nelson, Chief Investigator to the...